Linked Life Data

122130

Source:http://linkedlifedata.com/resource/pubmed/id/122130

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
1981-4-24
pubmed:abstractText
Twenty patients aged between 7 and 19 years with confirmed vesical schistosomiasis due to Schistosoma haematobium were treated with Metrifonate (Dipterex, Bilarcil) orally on a single dose of 7.5 mg/kg body weight repeated at fortnightly intervals until egg excretion ceased. This was achieved with a maximum of three doses. No symptoms of toxicity or significant side effects were observed. Four patients remained symptom free of the infection for up to three years after the initial treatment. These results suggest that Metrifonate (Bilarcil), a cheap, relatively non-toxic, orally administered and effective drug against Schistosoma haematobium, can be used successfully in the management of this crippling infection. They also suggest that, provided there is no re-exposure, the subjects can remain free of symptoms for more than three years.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
0303-691X
pubmed:author
pubmed:issnType
Print
pubmed:volume
5
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
19-24
pubmed:dateRevised
2004-11-17
pubmed:meshHeading
pubmed:year
1979
pubmed:articleTitle
Preliminary report on long term cure of schistosomiasis using metrifonate (Bilarcil/Dipterex)--a new antischistosomal drug.
pubmed:publicationType
Journal Article